Möchten Sie immer auf dem neuesten Stand bleiben?

The analysis explores how AI-driven innovations are transforming skin disease detection, treatment planning and aesthetic dermatology procedures.

Thanks to the support of the Linda and Mike Mussallem Foundation, Octane has launched the Octane Mussallem Cardiovascular Accelerator.

In a capital-constrained market with selective investment, Keiretsu Forum-MST is demonstrating how discipline produces investable companies.

Elutia presents at Planet MicroCap 2026, discussing its drug-eluting biomatrix technology targeting post-surgical infection in breast reconstruction.

VANCOUVER, BC, June 11, 2026 (GLOBE NEWSWIRE) -- VVT Med Inc. (TSXV: VVTM) ("VVT Med" or the "Company"), a developer of minimally invasive, non-thermal, non-tumescent ("NT-NT") solutions for venous...

Urteste S.A. enrolled the first patient in the Panuri pancreatic cancer study; interim analysis results are expected in Q4 2026.

Independent, Peer-Reviewed Study Demonstrated Significant Improvement in Patient Outcomes, Reduction in Over 350 Nursing Hours in Year One, and 20% Decrease in Repeat Imaging Validates Value of...

Providence, RI, June 02, 2026 (GLOBE NEWSWIRE) -- Signati™ Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption...

MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...

ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at...